Psychiatry and Mental Health

Host: Cathleen Margolin, PhD

Guest: Steven Garlow, MD, PhD

Host Dr. Cathleen Margolin interviews Dr. Steven Garlow of Emory University School of Medicine about his recently published article in the Journal of American College Health. Dr. Garlow and colleagues studied an interactive web-based method of outreach to college students at risk for suicide.

Host: Cathleen Margolin, PhD

Guest: Steven Garlow, MD, PhD

Dr. Steven Garlow of the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine joins host, Dr. Cathleen Margolin, to talk about the challenges of finding young adults who are at risk for suicide. He also discusses the elevated risk of suicide among physicians.

Host: Cathleen Margolin, PhD

Guest: Steven Garlow, MD, PhD

What are the key warning signs of a potential suicide in young adults? How can we, as clinicians, act to prevent these devastating tragedies from occurring? Dr. Steven Garlow, assistant professor of psychiatry at Emory University School of Medicine, discusses suicide prevention for the post-high school population with host Dr. Cathleen Margolin.

Host: Leslie P. Lundt, MD

Guest: Roger McIntyre, MD

It is reported that up to a fifth of bipolar disorder patients will commit suicide, yet there are few studies looking at clinical risk factors in this population. What is the latest research? Host Dr. Leslie Lundt welcomes Dr. Roger McIntyre, associate professor of psychiatry and pharmacology at the University of Toronto School of Medicine, to discuss his latest research investigating childhood abuse with adult bipolar suicide rates.

Host: Leslie P. Lundt, MD

Guest: Roger McIntyre, MD

Substance abuse, obesity and bipolar disorder are major public health problems. They frequently co-occur, but what is the relationship between substance abuse and obesity in bipolar disorder? Dr. Roger McIntyre, associate professor of psychiatry and pharmacology at the University of Toronto and head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada, joins host Dr. Leslie Lundt to discuss his surprising research findings.

Host: Leslie P. Lundt, MD

Guest: Matthew W. Johnson, PhD

It used to be common for researchers to study the potential medicinal uses for hallucinogenic drugs, including psilocybin, ecstasy, and LSD; however, the 60's left a blemish on legitimate research and it grinded to a halt. Host Dr. Leslie Lundt welcomes Dr. Matthew Johnson, a psychopharmacologist in the Department of Psychiatry at the Johns Hopkins School of Medicine, who is studying psychoactive drug effects in human participants.

Host: Leslie P. Lundt, MD

Guest: Peter R. Breggin, MD

Our guest Dr. Peter Breggin, a psychiatrist now in private practice in Ithica New York has been convinced by the weight of scientific evidence and his years of clinical experience that psychiatric medications frequently cause patients to lose their judgment and their ability to control their emotions and actions. Needless to say, he is a controversial figure in our field. He joins host Dr. Leslie Lundt to discuss why he believes that psychotropics "spellbind" patients.

Host: Leslie P. Lundt, MD

Guest: Rebecca Puhl, MS, PhD

Obesity is associated with multiple medical and psychological co-morbidities. An often under recognized problem is that of weight related stigmatization which can lead to unfair treatment, prejudice and discrimination. Are you guilty? Dr. Rebecca Puhl, director of research and anti-stigma initiatives at the Rudd Center for Food Policy and Obesity at Yale University, joins host Dr. Leslie Lundt to explain how weight bias may affect your obese patients.

Host: Leslie P. Lundt, MD

Guest: Robert M. Post, MD

Mixed bipolar episodes as defined by the DSM-IV are relatively rare. But for those of us in clinical practice, this definition may be too conservative to be of use. What is a mixed bipolar episode and how do we best treat these patients? Host Dr. Leslie Lundt welcomes Dr. Robert Post, professor of psychiatry at George Washington University School of Medicine and Penn State College of Medicine, to discuss the management of mixed episodes.

Host: Leslie P. Lundt, MD

Guest: Robert M. Post, MD

The efficacy of the gold standard for bipolar treatment as been reported to be as high as 80%. But in the real world, that number is more like 25%. Why the disparity? What can we do for our treatment resistant bipolar patients? Dr. Robert Post professor of psychiatry at George Washington University School of Medicine and Penn State College of Medicine and head of the Bipolar Collaborative Network joins host Dr. Leslie Lundt to give us the latest on how to diagnose and treat these patients.